Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 29;8(8):CD016207.
doi: 10.1002/14651858.CD016207.

Pharmacological antiemetic prophylaxis and treatment for opioid-induced nausea and vomiting (OINV) in patients treated for cancer pain and cancer-related breathlessness

Affiliations

Pharmacological antiemetic prophylaxis and treatment for opioid-induced nausea and vomiting (OINV) in patients treated for cancer pain and cancer-related breathlessness

Jan Gaertner et al. Cochrane Database Syst Rev. .

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of pharmacological treatments given prophylactically or on-demand after onset of opioid-induced nausea and vomiting (OINV) in people being treated for cancer pain or cancer dyspnoea, when compared to placebo or other pharmacological interventions.

PubMed Disclaimer

Conflict of interest statement

  1. JG: no commercial or non‐commercial conflicts of interest relevant to this review. He is a specialist palliative care physician and manages palliative care patients.

  2. CAH: no commercial or non‐commercial conflicts of interest relevant to this review. He works as a medical information specialist.

  3. VP: no commercial or non‐commercial conflicts of interest relevant to this review.

  4. GS: received personal consulting fees for 'External statistical consultant of Roche Pharma AG, Grenzach‐Wyhlen, Germany'

  5. CR: no commercial or non‐commercial conflicts of interest relevant to this review. She is a pharmacist leading the Competence Centre for Palliative Pharmacy.

  6. KS: no commercial or non‐commercial conflicts of interest relevant to this review. She is a pharmacist and project manager.

  7. CB: planned an investigator‐initiated study that is potentially eligible for inclusion [52]. Therefore, he will not make study eligibility decisions about this study; if it is included, he will not extract data from it, carry out the risk of bias assessment, or perform GRADE assessments for comparisons and outcomes that include this study (section 5.6 of Cochrane’s Conflict of Interest Policy). CB is a specialist palliative care physician and manages palliative care patients.

Similar articles

References

    1. Dudgeon DJ, Kristjanson L, Sloan JA, Lertzman M, Clement K. Dyspnea in cancer patients. Journal of Pain and Symptom Management 2001;21(2):95-102. [DOI: 10.1016/S0885-3924(00)00258-X] - DOI - PubMed
    1. Henson LA, Maddocks M, Evans C, Davidson M, Hicks S, Higginson IJ. Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and fatigue. Journal of Clinical Oncology 2020;38(9):905-14. [DOI: 10.1200/JCO.19.00470] - DOI - PMC - PubMed
    1. Snijders R, Brom L, Theunissen M, Van Den Beuken-van Everdingen M. Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis. Cancers 2023;15(3):591. [DOI: 10.3390/cancers15030591] - DOI - PMC - PubMed
    1. Laugsand EA, Kaasa S, Klepstad P. Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliative Medicine 2011;25(5):442-53. [DOI: 10.1177/0269216311404273] - DOI - PubMed
    1. Sande TA, Laird BJA, Fallon MT. The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review. Journal of Palliative Medicine 2019;22(1):90-7. [DOI: 10.1089/jpm.2018.0260] - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources